Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners. [PDF]
Hasselbalch HC.
europepmc +1 more source
Comprehensive Chemoproteomics Unveils Selective HMG-CoA Synthase 1 Inhibitors for Targeting Mevalonate Metabolism in Cancer. [PDF]
Sun L +7 more
europepmc +1 more source
Artificial Multidomain Ribosomally Synthesized and Post-translationally Modified Peptide Enzymes for Farnesylated Peptide Library Generation. [PDF]
Lacerna N, Schmidt EW.
europepmc +1 more source
Iridium-Catalyzed Regio- and Enantioselective Reverse Prenylation of Tryptamines and Other 3-Substituted Indoles. [PDF]
Sander L, Müller JM, Stark CBW.
europepmc +1 more source
Targeting ICMT: A promising strategy in cancer treatment (Review). [PDF]
Hu J, Xiao Y, Tang J.
europepmc +1 more source
Synthesis of Okaramine M, Its Conversion to Amauromines, and Concise Bidirectional and Biomimetic Total Synthesis of Amauromines. [PDF]
Schmelzer D, Stark CBW.
europepmc +1 more source
Mevalonate metabolites boost aged oocyte quality through prenylation of small GTPases. [PDF]
Liu C +20 more
europepmc +1 more source
Biosynthesis of <i>ent</i>-acu-dioxomorpholine A and its conversion to prenyl-rearranged and rare ketooxadiazepane products in heterologous host. [PDF]
Tao Q, Zou Y.
europepmc +1 more source
<i>In Vivo</i> Metabolic Labeling with an Isoprenoid Probe Reveals APOE Allele-Specific Differences in the Prenylome. [PDF]
Petre AM +6 more
europepmc +1 more source
Identification of Glycosylated and Prenylated (Iso)flavonoids Using cIMS-MS. [PDF]
de Bruin CR +4 more
europepmc +1 more source

